GLP-1 Medications: The Good, The Bad, and What's Next

Let's have an honest conversation about the most talked-about drugs in modern medicine.

GLP-1 receptor agonists — brand names like Ozempic, Wegovy, Mounjaro, and Zepbound — have gone from diabetes medications to cultural phenomena in under three years. They're on magazine covers, dominating dinner party conversations, and reshaping entire industries from fashion to food. But between the breathless hype and the fear-based headlines, most people still don't have a clear, fact-based picture of what these drugs actually do, what they cost, and what happens when you stop taking them.

So let's break it down. No judgment. Just data, context, and options.

How They Work (The Science, Simplified)

GLP-1 stands for glucagon-like peptide-1 — a hormone your body naturally releases after you eat. It tells your brain you're full, triggers insulin release to regulate blood sugar, and slows down how fast your stomach empties so you stay satisfied longer.

GLP-1 medications mimic that hormone, but at much higher and more sustained levels than your body produces on its own. The result? Significantly reduced appetite, fewer cravings, and for many people, substantial weight loss. Clinical trials have shown average weight reductions of 15 to 20 percent of body weight — far more than any previous obesity medication could deliver. For a 220-pound person, that's roughly 33 to 44 pounds over about 68 weeks.

And the benefits extend beyond the scale. A major WashU Medicine study analyzing 175 health outcomes found that GLP-1 users showed reduced risks of heart attack, stroke, seizures, neurocognitive disorders like Alzheimer's, and even reduced substance addiction behaviors. The drugs appear to act on brain receptors involved in impulse control and reward — which may explain why users frequently describe the disappearance of "food noise," that constant mental chatter about what to eat next.

As of late 2025, the FDA also approved the first oral GLP-1 pill for weight loss (the Wegovy pill), and in early 2026, a second pill called Foundayo (orforglipron) was approved — expanding options beyond weekly injections for the first time.

The Celebrity Factor: Success Stories and Cautionary Tales

Part of what catapulted GLP-1s into the mainstream was celebrity transparency. And to their credit, several public figures have been refreshingly honest about their experiences — both the wins and the struggles.

Oprah Winfrey began taking a GLP-1 medication in 2023 after decades of public weight struggles. She's described the experience as "relief" and "redemption," and has spoken openly about using it as a tool alongside diet and lifestyle changes. But she also revealed that when she stopped the medication for a period, she regained 20 pounds — reinforcing a critical point about these drugs that we'll get to shortly.

Kathy Bates lost 100 pounds total — 80 through years of diet and exercise changes after a type 2 diabetes diagnosis, and another 20 after adding Ozempic. She's been clear that the medication wasn't a shortcut, telling interviewers the process took hard work, patience, and determination over several years.

Whoopi Goldberg shared that she lost the equivalent of "almost two people" on Mounjaro after weighing nearly 300 pounds during the filming of Till. Kelly Clarkson revealed she takes a GLP-1 (not Ozempic, she's specified) after her doctor pushed for two years because her bloodwork had gotten dangerously poor. Serena Williams turned to a GLP-1 after struggling to lose post-pregnancy weight despite intense exercise, pointedly rejecting the idea that medication equals a shortcut.

Now here's the thing…

Not every story is a victory lap. Sharon Osbourne has been perhaps the most candid cautionary voice. She admitted she lost 42 pounds in just four months on Ozempic — and then couldn't stop losing. She's publicly said she "went too far," dropped under 100 pounds, and has been unable to regain weight despite stopping the medication. Amy Schumer tried both Wegovy and Mounjaro but discontinued due to side effects she couldn't tolerate. And model Brooks Nader acknowledged that while the drug boosted her career, it had become a "crutch" she wanted to break free from.

These aren't edge cases. They represent the real spectrum of GLP-1 experiences.

The Risks and Trade-Offs Nobody Should Ignore

Let's talk about what the data actually shows on the downside.

Gastrointestinal side effects are common. Nausea, vomiting, diarrhea, and constipation are the most frequently reported issues — significant enough that some patients discontinue treatment entirely.

Lean mass loss is a real concern. Some clinical data indicates that up to 25 to 40 percent of weight lost on GLP-1 medications can come from lean body mass — not just fat. However, emerging research suggests this may not be disproportionate compared to other weight loss methods, and that much of the measured lean mass reduction comes from organ tissue (particularly liver), not skeletal muscle. Still, for anyone over 40 who's already losing muscle naturally, this warrants serious attention.

Weight regain after stopping is the norm, not the exception. A University of Cambridge analysis found that within a year of stopping GLP-1 medications, people regain on average 60 percent of their lost weight. Approximately half of all patients discontinue these drugs within the first year, and three-quarters stop within two years. A recent study also found that stopping GLP-1s for as little as six months can reverse the cardiovascular benefits gained while taking them.

The cost is significant. Ozempic runs approximately $1,200 per month without insurance, and coverage varies widely. These are designed as long-term — potentially lifelong — medications. That financial reality shapes who can access them and for how long.

That's the real issue. These drugs work — often remarkably well — but they're designed to be taken indefinitely, and the moment you stop, biology reasserts itself.

For Those Who Prefer a Different Path: What Actually Works

Not everyone wants to go the pharmaceutical route, and that's a completely valid choice. The key is choosing strategies that have actual evidence behind them — not Instagram trends.

The Mediterranean diet remains the gold standard. It's the most studied dietary pattern in nutrition science, with strong evidence for weight management, cardiovascular protection, reduced inflammation, and improved insulin sensitivity. A review published in the Journal of the American College of Cardiology specifically highlighted a Pesco-Mediterranean approach — emphasizing vegetables, fruits, nuts, legumes, whole grains, extra-virgin olive oil, and seafood as the primary animal protein — as having robust cardioprotective evidence.

Time-restricted eating shows real promise. Confining your eating to an 8-to-12-hour window daily — a form of intermittent fasting — has demonstrated benefits for weight loss, blood sugar regulation, and metabolic health. A 2025 randomized clinical trial found that calorie-restricted versions of time-restricted eating and alternate-day fasting produced comparable or even greater short-term weight loss than the Mediterranean diet alone. The combination of Mediterranean-style eating within a time-restricted window may offer the strongest synergistic benefit.

Protein-forward eating protects your engine. Research consistently shows that adults over 40 need approximately 1.0 to 1.2 grams of protein per kilogram of body weight daily to maintain muscle mass — the metabolically active tissue that keeps your resting metabolism running. Prioritizing protein at every meal (25 to 30 grams per serving) supports muscle retention during any weight loss approach.

Resistance training is non-negotiable. Whether you're on a GLP-1, following a Mediterranean diet, or doing intermittent fasting, strength training is the single most powerful intervention for preserving lean mass during weight loss. Two to four sessions per week of compound movements creates the stimulus your body needs to hold onto muscle while shedding fat.

The Bottom Line

GLP-1 medications are a legitimate medical breakthrough. They've changed the conversation about obesity from willpower failure to treatable condition, and for millions of people — particularly those with type 2 diabetes, cardiovascular risk, or severe obesity — they represent a genuinely life-changing tool.

But they're not magic. They come with trade-offs, they require long-term commitment, and they work best when paired with the lifestyle fundamentals that matter regardless of whether you ever take a prescription: strength training, adequate protein, quality sleep, and stress management.

And for those who choose not to go the medication route? That's okay too. There is more than one path to health and wellness, and we are here to support you on your journey!

Whatever path you choose, choose it informed. That's the only move that actually wins.

— Karma